EVH Earnings Evolent Health, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -0.49 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.24 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -5.07 | 2026-02-25 | 10-K |
| FY 2025 | 2025-09-30 | -0.24 | 2026-02-25 | 10-K |
| Q2 2026 | 2025-06-30 | -1.07 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.63 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.81 | 2026-02-25 | 10-K |
| FY 2025 | 2024-09-30 | -0.27 | 2026-02-25 | 10-K |
| FY 2025 | 2024-06-30 | -0.06 | 2026-02-25 | 10-K |
| FY 2025 | 2024-03-31 | -0.22 | 2026-02-25 | 10-K |
| FY 2025 | 2023-12-31 | -1.28 | 2026-02-25 | 10-K |
| FY 2024 | 2023-09-30 | -0.30 | 2025-02-21 | 10-K |
| FY 2024 | 2023-06-30 | -0.37 | 2025-02-21 | 10-K |
| FY 2024 | 2023-03-31 | -0.24 | 2025-02-21 | 10-K |
| FY 2024 | 2022-12-31 | -0.20 | 2025-02-21 | 10-K |
| FY 2023 | 2022-09-30 | 0.02 | 2024-02-23 | 10-K |
| FY 2023 | 2022-06-30 | -0.05 | 2024-02-23 | 10-K |
| FY 2023 | 2022-03-31 | -0.06 | 2024-02-23 | 10-K |
| FY 2023 | 2021-12-31 | -0.44 | 2024-02-23 | 10-K |
| Q3 2022 | 2021-09-30 | -0.37 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.22 | 2022-08-03 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.12 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | -3.94 | 2023-02-24 | 10-K |
| Q3 2021 | 2020-09-30 | -3.87 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -3.32 | 2021-08-05 | 10-Q |
| FY 2021 | 2020-03-31 | -0.93 | 2021-05-06 | 10-Q |
| FY 2021 | 2019-12-31 | -3.67 | 2022-02-24 | 10-K |
| Q3 2019 | 2019-09-30 | -1.27 | 2019-11-05 | 10-Q |
| Q2 2019 | 2019-06-30 | -0.97 | 2019-08-09 | 10-Q |
| Q1 2019 | 2019-03-31 | -0.59 | 2019-05-09 | 10-Q |
| Q3 2019 | 2018-09-30 | -0.47 | 2019-11-05 | 10-Q |
| Q2 2019 | 2018-06-30 | -0.31 | 2019-08-09 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.18 | 2019-05-09 | 10-Q |
| FY 2017 | 2017-12-31 | -0.94 | 2018-03-01 | 10-K |
| Q3 2018 | 2017-09-30 | -0.78 | 2018-11-08 | 10-Q |
| Q2 2018 | 2017-06-30 | -0.62 | 2018-08-09 | 10-Q |
| Q1 2018 | 2017-03-31 | -0.34 | 2018-05-10 | 10-Q |
| FY 2017 | 2016-12-31 | -3.55 | 2018-03-01 | 10-K |
| FY 2017 | 2016-09-30 | -0.26 | 2018-03-01 | 10-K |
| FY 2017 | 2016-06-30 | -0.20 | 2018-03-01 | 10-K |
| FY 2017 | 2016-03-31 | -2.91 | 2018-03-01 | 10-K |
| FY 2017 | 2015-12-31 | 6.93 | 2018-03-01 | 10-K |
| FY 2016 | 2015-09-30 | -0.29 | 2017-03-03 | 10-K |
| FY 2016 | 2015-06-30 | 9.73 | 2017-03-03 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.